-
Active Watch List: Conatus Pharmaceuticals Inc. (NASDAQ:CNAT), xG Technology (NASDAQ:XGTI), Tidewater Inc. (NYSE:TDW), Fidelity National Financial (NYSE:FNF), Vulcan Materials (NYSE:VMC)
On Monday shares of Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) closed at $6.10. Company’s EPS growth for next 5 years is recorded as 1.00%. Conatus Pharmaceuticals Inc. (NASDAQ:CNAT), announced that it will report financial results for the first quarter ended March 31, 2015, after the market close on Thursday, May 7, 2015. xG Technology, Inc. (NASDAQ:XGTI) in…
-
Fast Moving Stocks: Facebook Inc (NASDAQ:FB), International Business Machines Corporation (NYSE:IBM), United Security Bancshares (NASDAQ:UBFO), Conatus Pharmaceuticals Inc. (NASDAQ:CNAT), Art’s-Way Manufacturing (NASDAQ:ARTW)
On Wednesday shares of Facebook Inc (NASDAQ:FB) closed at $80.46. Company’s sales growth for last 5 years was 74.20% and EPS growth for next 5 years is recorded as 26.98%. On 28 April, Facebook Inc (NASDAQ:FB) said that, it is currently working with a select group of partners to launch desktop video app ads in…
-
Hot Stocks: Wowo Limited (NASDAQ:WOWO), Intel Corporation (NASDAQ:INTC), Conatus Pharmaceuticals Inc. (NASDAQ:CNAT), International Business Machines Corporation (NYSE:IBM), HEICO Corporation (NYSE:HEI)
On Thursday shares of Wowo Limited (NASDAQ:WOWO) closed at $8.84. On 15 April, Wowo Limited (NASDAQ:WOWO) said that, Citi, has been appointed by Wowo Limited (“WOWO”), as the Depositary Bank for its American Depositary Receipt (“ADR”) program. On last trading day Intel Corporation (NASDAQ:INTC) moved down -1.07% to close at $32.35. Its volatility for the…
-
Whats Hot Today: Conatus Pharmaceuticals Inc. (NASDAQ:CNAT), Heat Biologics (NASDAQ:HTBX), Curtiss-Wright Corporation (NYSE:CW), Rite Aid Corporation (NYSE:RAD), Inovio Pharmaceuticals (NASDAQ:INO)
On Thursday shares of Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) closed at $6.65. Company’s EPS growth for next 5 years is recorded as 1.00%. Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) announced that three posters addressing clinical results with emricasan, the company’s first-in-class, orally active pan-caspase protease inhibitor, have been accepted for presentation at The International Liver Congress™ 2015, the…
-
Morning Alert: Zynga (NASDAQ:ZNGA), Office Depot (NASDAQ:ODP), National Health Investors (NYSE:NHI), Fortune Brands Home & Security (NYSE:FBHS), Conatus Pharmaceuticals Inc. (NASDAQ:CNAT)
On Friday shares of Zynga Inc (NASDAQ:ZNGA) closed at $2.49. Company’s sales growth for last 5 years was 41.50% and EPS growth for next 5 years is recorded as 30.00%. On April 08, Mark Pincus has returned to his role of CEO at Zynga Inc (NASDAQ:ZNGA), a company he founded in 2007. Zynga (ZNGA), maker…
-
Whats Hot Today: Petroleo Brasileiro Petrobras (NYSE:PBR), Conatus Pharmaceuticals Inc. (NASDAQ:CNAT), TAL Education Group (NYSE:XRS), Franklin Covey (NYSE:FC), Transition Therapeutics Inc. (NASDAQ:TTHI)
On Thursday shares of Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR) closed at $6.76. Company’s sales growth for last 5 years was 3.60% and EPS growth for next 5 years is recorded as 1.50%. Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR) may be putting itself in the company of some of Latin America’s most distressed borrowers by…
-
Traders Are Watching: National Bank of Greece (ADR) (NYSE:NBG), Conatus Pharmaceuticals Inc. (NASDAQ:CNAT), Synaptics Inc. (NASDAQ:SYNA), Petroleo Brasileiro Petrobras (NYSE:PBR), BlackBerry (NASDAQ:BBRY)
National Bank of Greece (ADR) (NYSE:NBG) in last trading activity fell -3.12% to close at $1.24. Company weekly performance is -8.82% while its quarterly performance stands at -30.73%. National Bank of Greece (ADR) (NYSE:NBG) is -78.58% away from its 52 week high. On 23 March 2015, National Bank of Greece (ADR) (NYSE:NBG) unveiled changes to…
-
Why Making Dramatic Moves: Conatus Pharmaceuticals (NASDAQ:CNAT), MER Telemanagement Solutions (NASDAQ:MTSL), Johnson & Johnson (NYSE:JNJ), CTI Industries (NASDAQ:CTIB), International Business Machines (NYSE:IBM)
On Wednesday shares of Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) closed at $6.81. Company’s EPS growth for next 5 years is recorded as 1.00%. Conatus Pharmaceuticals (NASDAQ: CNAT) announced that it intends to offer and sell shares of its common stock in an underwritten public offering. MER Telemanagement Solutions Ltd. (NASDAQ:MTSL) in last trading activity decreased -1.90%…
-
Hot News: Conatus Pharmaceuticals (NASDAQ:CNAT), American International Group (NYSE:AIG), Dish Network Corp. (NASDAQ:DISH), Fairpoint Communications (NASDAQ:FRP), GNC Holdings Inc. (NYSE:GNC)
On Monday shares of Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) closed at $7.53. Company’s EPS growth for next 5 years is recorded as 1.00%. On March 27, Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) announced top-line results from a phase II double-blind, placebo-controlled study (n=38) on emricasan, in patients with nonalcoholic fatty liver disease (NAFLD), including a subset of NAFLD…
-
Trader’s Recap: Intel Corporation (NASDAQ:INTC), Conatus Pharmaceuticals Inc. (NASDAQ:CNAT), Ambac Financial Group (NASDAQ:AMBC), MSCI Inc. (NYSE:MSCI), DigitalGlobe (NYSE:DGI)
On last trading day Intel Corporation (NASDAQ:INTC) moved down -0.49% to close at $30.74. Its volatility for the week is 1.78% while volatility for the month is 2.11%. INTC’s sales growth for past 5 years was 9.70% and its EPS growth for past 5 years was 24.60%. Intel Corporation (NASDAQ:INTC) monthly performance is -10.30%. On…